APG-115
Showing 1 - 25 of 152
Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)
Recruiting
- Malignant Salivary Gland Cancer
- Salivary Gland Cancer
- APG-115
- Carboplatin
-
Tampa, Florida
- +2 more
Feb 10, 2022
Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndromes (MDS)
- APG-115
- +2 more
-
Beijing, Beijing, China
- +13 more
Aug 16, 2022
Liposarcoma, Advanced Solid Tumor Trial in Guangzhou, Shanghai (APG-115, Toripalimab)
Recruiting
- Liposarcoma
- Advanced Solid Tumor
- APG-115
- Toripalimab
-
Guangzhou, Guangdong, China
- +1 more
Sep 22, 2021
ADHD Trial in United States (Amphetamine Sulfate, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- Amphetamine Sulfate
- Placebo
-
Encino, California
- +30 more
Oct 20, 2020
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)
Recruiting
- Nasopharyngeal Carcinoma
- +8 more
-
Springdale, ArkansasHighlands Oncology
Nov 11, 2022
Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ Trial in Miami (APG-157)
Not yet recruiting
- Oropharyngeal Dysplasia
- +2 more
-
Miami, FloridaUniversity of Miami
May 9, 2023
Anemia Trial in Guangzhou (APG-5918, Placebo)
Not yet recruiting
- Anemia
- APG-5918
- Placebo
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medical University
Mar 6, 2023
Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen
Not yet recruiting
- Metastatic Endometrial Carcinoma
- +7 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Androgenetic Alopecia Trial in Beijing (-Q2W, HMI-115-120mg-Q4W, HMI-115-240mg-Q4W)
Recruiting
- Androgenetic Alopecia
- placebo-Q2W
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 3, 2023
Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)
Active, not recruiting
- Tumor Skin
- +2 more
- OBX-115
-
Orlando, Florida
- +1 more
Sep 28, 2023
Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia Trial in
Not yet recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +3 more
- Olverembatinib, APG-2575, Dexamethasone
-
Hefei, Anhui, China
- +3 more
Aug 8, 2022
Contrast Induced Acute Kidney Injury Trial (Isuzinaxib (APX-115), Placebo)
Not yet recruiting
- Contrast Induced Acute Kidney Injury
- Isuzinaxib (APX-115)
- Placebo
- (no location specified)
Feb 24, 2023
Advanced Solid Tumor Trial in Foshan, Guangzhou, Nanning (APG-1387 for Injection, Toripalimab)
Recruiting
- Advanced Solid Tumor
- APG-1387 for Injection
- Toripalimab
-
Foshan, Guangdong, China
- +2 more
Oct 18, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (APG2575)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Bengbu, Anhui, China
- +45 more
Jun 30, 2022